March 30, 2022
RUXOLITINIB AS A TREATMENT STRATEGY FOR SARS-CoV-2 PNEUMONIA: CLINICAL EXPERIENCE IN...
Roberto Ovilla-Martinez, Xochitl Cota-Rangel, Jose De La Peña-Celaya, et al.